Q32 Bio 2024年第四季度每股亏损1.16美元,好于预期的1.51美元,预计现金及现金等价物为7800万美元,可支持到2026年下半年

财报速递
11 Mar
Q32 Bio(纳斯达克代码:QTTB)报告季度每股亏损1.16美元,优于分析师预期的每股亏损1.51美元,超出预期23.18%。

以上内容来自Benzinga Earnings专栏,原文如下:

Q32 Bio (NASDAQ:QTTB) reported quarterly losses of $(1.16) per share which beat the analyst consensus estimate of $(1.51) by 23.18 percent.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10